Skip to main content

Posts

Showing posts with the label Milder therapeutic drugs

Hippocampus

 Hippocampus, which is known to encode a new protein called PGC-1α that acts as a strong synaptic activator in the hippocampus.  The fact of course remains there are many factors involved with stress and cognitive dysfunction including loss or disease of brain cells - but since we know this can happen more frequently then you might think people would assume it's related to the illness so doctors look for clues if they get an old wound on their scalp from being spanked/tossed around all day long?  Hippocampus in humans and other primates is associated with anxiety-like behavior. In addition to the hippocampal dysfunction that may be involved here, we are interested herein also in how impaired brain function relates directly or indirectly using a novel model of neurodegenerative diseases. We observed previously in Alzheimer's disease patients reduced cognitive performance on measures of attention span across two tests—the spatial working memory task and an executive function test

Milder therapeutic drugs

 Milder therapeutic drugs (such as riluzole) to help with nausea and vomiting. However, these medications have not yet been proven effective in treating this debilitating condition. A combination of several common antibiotics has shown success against severe cases but is rarely used for patients who do well on multiple classes," said Dr Richard Weisberg at University College London's Wellcome Trust Surgical Centre, where the research was carried out alongside Professor Nick Brown of Edinburgh University's School Of Hygiene & Tropical Medicine. The researchers tested 23 participants that had a history or present medical problem caused by chronic fatigue syndrome - one third were taking an antibiotic known collectively among clinicians as cephalosporins. In addition, treatment with intravenous corticosteroids was sometimes used in a subset of patients who presented a severely compromised immune status despite aggressive therapy for advanced cancer. The authors conclude t